Oligonucleotide therapies: the past and the present
KE Lundin, O Gissberg, CIE Smith - Human gene therapy, 2015 - liebertpub.com
In this review we address the development of oligonucleotide (ON) medicines from a
historical perspective by listing the landmark discoveries in this field. The various biological …
historical perspective by listing the landmark discoveries in this field. The various biological …
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart
BC Bernardo, JYY Ooi, RCY Lin… - Future medicinal …, 2015 - Taylor & Francis
miRNAs are small non-coding RNAs (ncRNAs), which regulate gene expression. Here, the
authors describe the contribution of miRNAs to cardiac biology and disease. They discuss …
authors describe the contribution of miRNAs to cardiac biology and disease. They discuss …
Compositions for treating muscular dystrophy
EM Kaye - US Patent 9,506,058, 2016 - Google Patents
2020-01-09 Assigned to BIOPHARMA CREDIT PLC reassignment BIOPHARMA CREDIT
PLC CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR APP. NO …
PLC CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR APP. NO …
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
US9447415B2 - Antisense oligonucleotides for inducing exon skipping and methods of use
thereof - Google Patents US9447415B2 - Antisense oligonucleotides for inducing exon skipping …
thereof - Google Patents US9447415B2 - Antisense oligonucleotides for inducing exon skipping …
Antisense molecules and methods for treating pathologies
SD Wilton, S Fletcher, A Adams, P Meloni - US Patent 9,228,187, 2016 - Google Patents
2015-08-10 Assigned to THE UNIVERSITY OF WESTERN AUSTRALIA reassignment THE
UNIVERSITY OF WESTERN AUSTRALIA ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
UNIVERSITY OF WESTERN AUSTRALIA ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
US9175286B2 - Antisense oligonucleotides for inducing exon skipping and methods of use
thereof - Google Patents US9175286B2 - Antisense oligonucleotides for inducing exon skipping …
thereof - Google Patents US9175286B2 - Antisense oligonucleotides for inducing exon skipping …
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
US9024007B2 - Antisense oligonucleotides for inducing exon skipping and methods of use
thereof - Google Patents US9024007B2 - Antisense oligonucleotides for inducing exon skipping …
thereof - Google Patents US9024007B2 - Antisense oligonucleotides for inducing exon skipping …
mCherry on Top: A Positive Read-Out Cellular Platform for Screening DMD Exon Skipping Xenopeptide–PMO Conjugates
AL Lessl, J Pöhmerer, Y Lin, U Wilk… - Bioconjugate …, 2023 - ACS Publications
Phosphorodiamidate morpholino oligomers (PMOs) are a special type of antisense
oligonucleotides (ASOs) that can be used as therapeutic modulators of pre-mRNA splicing …
oligonucleotides (ASOs) that can be used as therapeutic modulators of pre-mRNA splicing …
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
US9441229B2 - Antisense oligonucleotides for inducing exon skipping and methods of use
thereof - Google Patents US9441229B2 - Antisense oligonucleotides for inducing exon skipping …
thereof - Google Patents US9441229B2 - Antisense oligonucleotides for inducing exon skipping …
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
US9249416B2 - Antisense oligonucleotides for inducing exon skipping and methods of use
thereof - Google Patents US9249416B2 - Antisense oligonucleotides for inducing exon skipping …
thereof - Google Patents US9249416B2 - Antisense oligonucleotides for inducing exon skipping …